checkpoint kinase 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| DNA damage checkpoint signaling |
|
|
| DNA damage checkpoint signaling |
|
|
| DNA damage checkpoint signaling |
|
|
| G2/M transition of mitotic cell cycle |
|
|
| inner cell mass cell proliferation |
|
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| chromosome, telomeric region |
|
|
| chromatin |
|
|
| chromatin |
|
|
| condensed nuclear chromosome |
|
|
| extracellular region |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein kinase activity |
|
|
| protein kinase activity |
|
|
| protein serine/threonine kinase activity |
|
|
| protein serine/threonine kinase activity |
|
|
| protein serine/threonine kinase activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:1793 | pancreatic cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026